We are live on
!
Find out more
WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$4.16B
1-Year Est. Return
30.77%
This Fund
S&P 500
This Quarter
Est. Return
+34.99%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.49B
AUM Growth
+$922M
(+36%)
Cap. Flow
+$316M
Cap. Flow
% of AUM
9.05%
Top 10 Holdings %
Top 10 Hldgs %
13.93%
Holding
651
New
247
Increased
146
Reduced
134
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$39.4M |
| 2 |
Freeport-McMoran
FCX
|
+$37.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$30.5M |
| 4 |
Qiagen
QGEN
|
+$28.5M |
| 5 |
Skyworks Solutions
SWKS
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$78.6M |
| 2 |
Union Pacific
UNP
|
+$43.1M |
| 3 |
Centene
CNC
|
+$31.2M |
| 4 |
AVYA
Avaya Holdings Corp. Common Stock
AVYA
|
+$30.8M |
| 5 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$29.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.26% |
| 2 | Industrials | 15.69% |
| 3 | Real Estate | 10.41% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Verizon
VZ
$201B
| $262K | 0.01% |
4,746
-45,254
| -91% | -$2.55M |
|
|
TBIO
502
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $262K | 0.01% |
+14,603
| New | +$220K |
|
|
SMAR
503
DELISTED
Smartsheet Inc.
SMAR
| $255K | 0.01% |
5,010
-14,014
| -74% | -$713K |
|
|
KALV
504
DELISTED
KalVista Pharmaceuticals
KALV
| $241K | 0.01% |
19,947
+686
| +4% | +$7.29K |
|
505
Motorola Solutions
MSI
$73.1B
| $236K | 0.01% |
1,682
-25,690
| -94% | -$3.64M |
|
|
CALT
506
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $233K | 0.01% |
+10,023
| New | +$199K |
|
507
Comcast
CMCSA
$85.8B
| $228K | 0.01% |
+5,840
| New | +$222K |
|
|
AKUS
508
DELISTED
Akouos Inc
AKUS
| $225K | 0.01% |
+10,000
| New | +$223K |
|
|
NETI
509
DELISTED
Eneti Inc.
NETI
| $223K | 0.01% |
+14,577
| New | +$285K |
|
|
ICAD
510
DELISTED
iCAD Inc
ICAD
| $218K | 0.01% |
21,858
-3,306
| -13% | -$35.7K |
|
511
Arrowhead Research
ARWR
$12.1B
| $216K | 0.01% |
+5,011
| New | +$177K |
|
512
Gogo Inc
GOGO
$550M
| $216K | 0.01% |
+68,455
| New | +$147K |
|
513
Voyager Therapeutics
VYGR
$184M
| $214K | 0.01% |
16,935
+582
| +4% | +$6.77K |
|
514
Dollar General
DG
$27.8B
| $212K | 0.01% |
+1,112
| New | +$201K |
|
515
Fennec Pharmaceuticals
FENC
$345M
| $210K | 0.01% |
25,123
-316
| -1% | -$2.35K |
|
516
Honeywell
HON
$78.3B
| $210K | 0.01% |
1,542
-18,567
| -92% | -$2.46M |
|
|
SAGE
517
DELISTED
Sage Therapeutics
SAGE
| $207K | 0.01% |
+4,986
| New | +$181K |
|
|
WBA
518
DELISTED
Walgreens Boots Alliance
WBA
| $204K | 0.01% |
+4,822
| New | +$205K |
|
519
uniQure
QURE
$2.52B
| $202K | 0.01% |
4,485
+153
| +4% | +$9.04K |
|
520
Yum China
YUMC
$15.6B
| $202K | 0.01% |
+4,205
| New | +$198K |
|
521
TherapeuticsMD
TXMD
$23.8M
| $193K | 0.01% |
3,086
+106
| +4% | +$6.17K |
|
|
SGMO
522
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $170K | ﹤0.01% |
18,992
+648
| +4% | +$6.01K |
|
|
AERI
523
DELISTED
Aerie Pharmaceuticals
AERI
| $163K | ﹤0.01% |
+11,054
| New | +$164K |
|
|
AGTC
524
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $100K | ﹤0.01% |
18,000
+2,556
| +17% | +$11.7K |
|
|
BRQS
525
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $81K | ﹤0.01% |
322
-164
| -34% | -$54.9K |
|
Similar funds
SS
PMEF
CC
GW
BC
GC
WP
BWM
Weiss Multi-Strategy Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, Weiss Multi-Strategy Advisers held 651 positions worth $3.49B, up 36% from $2.57B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Weiss Multi-Strategy Advisers deployed $316M of net new capital in Q2 2020, opening 247 new positions and adding to 146 existing holdings. Its largest new stake was People Inc: 887,090 shares worth $51.3M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 26% a quarter earlier, followed by Industrials and Real Estate.
On the sell side, the largest reduction was Union Pacific, an estimated $43.1M trimmed.
- Weiss Multi-Strategy Advisers's largest Q2 2020 buy was People Inc: 887,090 shares worth $51.3M.
- Weiss Multi-Strategy Advisers added most to Qiagen in Q2 2020, an estimated $28.5M increase.
- Weiss Multi-Strategy Advisers's biggest Q2 2020 reduction was Union Pacific, cutting an estimated $43.1M.
- Weiss Multi-Strategy Advisers fully exited Allergan plc in Q2 2020, selling an estimated $78.6M.
- Weiss Multi-Strategy Advisers's ten largest holdings make up 14% of its $3.49B portfolio in Q2 2020.
- Weiss Multi-Strategy Advisers opened 247 new positions and closed 123 in Q2 2020.
- Weiss Multi-Strategy Advisers's portfolio value rose 36% quarter-over-quarter to $3.49B.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.